Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.
about
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesCytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity.A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivoBerberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.In vitro self-assembly of tailorable nanotubes from a simple protein building blockOral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Rise of the nanomachine: the evolution of a revolution in medicine.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Nanoparticle strategies for the oral delivery of insulin.Small-molecule delivery by nanoparticles for anticancer therapyStrategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Recent advances in the field of nanometric drug carriers.Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.Organic/hybrid nanoparticles and single-walled carbon nanotubes: preparation methods and chiral applications.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Nanodevices for the immobilization of therapeutic enzymes.Nanocarrier-based interventions for the management of MDR/XDR-TB.Why most oral insulin formulations do not reach clinical trials.Nanotechnology-based drug delivery of ropinirole for Parkinson's disease.An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.Peptide nanostructures in biomedical technology.Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents.Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium.Polymeric nanoparticles loaded with the 3,5,3'-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics.Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration.Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment.Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges.Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine deliveryCurcumin-loaded sterically stabilized nanodispersion based on non-ionic colloidal system induced by ultrasound and solvent diffusion-evaporation
P2860
Q27028129-77BD7D5D-A12A-478F-9C6B-2A567E3BC923Q30374697-F71106DA-D1D6-42E7-9910-8BA84277C09FQ30431343-05946AC7-4FC3-4C1B-B0C4-8CDD3C23905AQ33640555-17E44019-CB53-4001-8CB8-E2C921DDDD26Q35236166-C9540FB8-0C14-46FD-AFAA-4FC28DC68F6CQ35577258-5B7B11A4-F526-4417-9448-AD11D56CC0D8Q36499282-227CF175-9E3E-49C1-B830-38A996F43852Q36917923-84DC0199-2AAD-41EE-9905-9FC9B48B5097Q36917938-A945E47E-1A43-484A-871A-344D55943417Q37015849-B5121CAE-D85E-478A-B2D8-C8FF4329188EQ37039026-BDA5EE2B-4A20-4869-9A09-F6225AB80D6DQ37059874-F2E957E6-9D58-4CDC-93AC-D84D3670255FQ37210480-414A7CE5-5299-42D9-9177-7BC514446B15Q37627442-86EF9AB9-AD65-493A-9D0B-D9ED2456B571Q37855847-BE703350-E322-4B68-A326-734B356667B0Q37948968-7F481A7A-8EED-47D6-881F-69E8E49A8D5FQ38076188-0B178D26-A33A-424E-A091-400A9D975807Q38210418-BE08ACEE-F683-4B6D-BE24-5051674A7FC1Q38266101-71276C8D-93D7-40C5-BC42-A54601447675Q38340160-3B2CCB68-65C5-4123-99A0-301DF8638ACAQ38375982-7CE5E0DC-99C9-4E0C-8BBC-FA7F9A941E6CQ38566437-4D0A1113-F52F-4D3F-8496-5AEECAAB1C44Q38637595-8BD079DD-38A4-4CDF-8B05-D5DD90402DA8Q38681052-441E117F-8D69-487E-8BE5-36BF0426E584Q38723306-B256AE23-D8DB-45D1-9D90-07F2DCCF64C5Q38814420-712E0EA1-B187-4EAA-8B83-22DBEA0050C3Q39576550-F20800EC-CF04-40EA-AC71-B37923272A38Q42055713-898B3632-4061-4401-84DE-89A10DC47465Q42207862-BFCAA65A-F68E-4612-98E2-8985C67B5F72Q42849111-B39AB90F-08D5-4846-B5B4-D2EA3C41978CQ44328880-61B61405-E8AC-4FA3-8F23-DC198D0E3F38Q55053689-0AC6C743-4CF2-457D-85F3-B92283A43C08Q57349484-6A883ADE-49F1-48B2-AC9F-B4E4E0F2D9F7Q58920733-1F70F927-60DD-41EB-ADF0-95EAE698CA26
P2860
Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@ast
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@en
type
label
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@ast
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@en
prefLabel
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@ast
Nanoencapsulation II. Biomedic ...... oparticulate delivery systems.
@en
P50
P1476
Nanoencapsulation II. Biomedic ...... noparticulate delivery systems
@en
P2093
Ronald J Neufeld
P356
10.1016/J.NANO.2006.04.009
P577
2006-06-01T00:00:00Z